Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclophosphamide in relapsing remitting multiple sclerosis.

F D'Andrea1, C D'Aurizio, C Marini

  • 1Clinica Neurologica dell'Università delgi Studi, L'Aquila.

Italian Journal of Neurological Sciences
|June 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Resonant Magnetic Perturbations on the Toroidal Location of the Runaway Electron Final Loss Strike Point.

Physical review letters·2026
Same author

First Demonstration of Resonant Pitch-Angle Scattering of Relativistic Electrons by Externally Launched Helicon Waves.

Physical review letters·2026
Same author

A near X-point charge exchange neutral spectroscopy (CENS) system for DIII-D.

The Review of scientific instruments·2024
Same author

Anisotropic atomic displacements, local orthorhombicity and anomalous local magnetic moment in Ba<sub>0.6</sub>K<sub>0.4</sub>Fe<sub>2</sub>As<sub>2</sub> superconductor.

Physical chemistry chemical physics : PCCP·2024
Same author

Snip conjunctivoplasty associated with methylene blue staining for treatment of postoperative conjunctival chemosis.

Case reports in plastic surgery & hand surgery·2024
Same author

Letter to the Editor: A new laser level App to improve nipple-areola complex symmetry in breast surgery.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2023
Same journal

Attualità in neurochirurgia : Edited by P. Paoletti, R. Kneich, R. Urcioli, C. Spairani Atti del XXXV Congresso Nazionale della Società Italiana di Neurochirurgia, September 1986. Mondadori Editore, 829 pages.

Italian journal of neurological sciences·2016
Same journal

24th Annual Meeting of the Italian Neuropathological Association : May 26-27-28, 1988 Napoli, Castel dell'Ovo.

Italian journal of neurological sciences·2016
Same journal

[Not Available].

Italian journal of neurological sciences·2016
Same journal

[Not Available].

Italian journal of neurological sciences·2016
Same journal

Pathogenesis and surgical treatment of neurovascular primary headaches.

Italian journal of neurological sciences·2016
Same journal

The complementary contribution of the rhinologist and the neurologist at the clinical study and treatment of the cluster headache.

Italian journal of neurological sciences·2016
See all related articles

Intravenous cyclophosphamide (CY) therapy may help manage relapsing-remitting multiple sclerosis (MS). This intensive treatment showed reduced relapse rates and clinical stability in most patients over three years.

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Relapsing-remitting MS (RRMS) is the most common form, characterized by distinct attacks and remissions.
  • Current treatments aim to reduce disease activity and manage symptoms.

Purpose of the Study:

  • To evaluate the efficacy of an intensive intravenous cyclophosphamide (CY) therapy in patients with RRMS.
  • To assess the long-term impact of CY on relapse rates and clinical progression in RRMS.

Main Methods:

  • Seven patients with RRMS received induction therapy with 11 daily doses of intravenous CY (300 mg/m2).
  • Patients continued with a single CY dose every six months for three years.

Related Experiment Videos

  • Follow-up included monitoring relapse rates and clinical stability over three years.

    • Main Results:

    • After one year, all patients experienced a significant decrease in relapse rate.
    • Over the subsequent two years, two patients showed mild worsening, while the remaining five remained clinically stable.
    • The treatment regimen was generally well-tolerated, with no severe adverse events reported.

    Conclusions:

    • Intravenous cyclophosphamide therapy appears to be a promising treatment for influencing the clinical course of RRMS.
    • The intensive CY regimen demonstrated sustained efficacy in reducing relapse rates and maintaining clinical stability.
    • Further research with larger cohorts is warranted to confirm these findings and optimize treatment protocols.